The European Society for Paediatric Endocrinology (ESPE) is an international organisation aiming to improve clinical care of children and adolescents with endocrine conditions, including diabetes, through research and education.

Paediatric endocrinology is a specialty of children’s medicine (paediatrics) caring for babies, children and adolescents with growth, puberty, sexual development problems and other disorders of the hormone producing glands of the body. These include diabetes, thyroid and adrenal gland problems, early and late puberty, bone conditions and growth hormone deficiency.

In 1962, following attendance to the 4th Acta Endocrinologica Congress in Geneva, Professor Andrea Prader invited 26 paediatricians and endocrinologists with an interest in foetal and paediatric issues to attend an informal post conference meeting and so the first ‘Paediatric Endocrinology Club’ was formed. These meetings provided young European Investigators with a platform to discuss Paediatric Endocrinology in-depth. ESPE was officially founded at the meeting in Copenhagen in 1965, with the mission ‘The Society shall promote knowledge of Paediatric Endocrinology in the widest Sense.’

The Society is also actively involved in promoting the interests of the general public and in advising on European health policy in the area of paediatric endocrinology. ESPE is also a founding member of the International Consortium of Pediatric Endocrinology (ICPE), which exists to foster global collaboration in paediatric endocrinology. The European Commission has officially designated ESPE as the body responsible for organising and monitoring training in paediatric endocrinology.

International scientific community > 1,500 members

Connecting peadiatric endocrinologists from >90 countries

Annual meeting attended by >3,500 delegates

Official designated body responsible for organising and monitoring training in the field

Mission

The mission of ESPE is to advance excellence in paediatric endocrinology, diabetes and bone disorders by promoting research, education and medical practice to the benefit of child and adolescent health throughout the world.

ESPE is also a founding member of the International Consortium of Pediatric Endocrinology (ICPE), which exists to foster global collaboration in paediatric endocrinology.

Vision

To be the leading society in paediatric endocrinology that aims for excellence in clinical care, research and education through innovation, collaboration and technology.

Strategy

  • Develop and assess evidence-based clinical standards of care
  • Organise and monitor training activities specifically designed to fulfil the specific needs of trainees
  • Work closely with other international organisations to expand and disseminate knowledge
  • Serve and communicate effectively with members at all stages of their career and practice in the field of paediatric endocrinology and diabetes
  • Facilitate international collaborations to promote scientific discovery and knowledge dissemination that will then impact on patient care
  • Work to the highest ethical standards

Governance

The European Society for Paediatric Endocrinology was incorporated as a company limited by guarantee, registered in England & Wales, company registration number 5766541. The constitution was changed following the Annual Business Meeting of 28th June 2007 in Helsinki, Finland.

The European Society for Paediatric Endocrinology Limited is governed by the following byelaws:

In addition, the limited company, the European Society for Paediatric Endocrinology Limited, is governed by the legal Memorandum & Articles of Association:


The European Society for Paediatric Endocrinology was registered with the Charity Commission on 28th January 2008, charity registration number 1122484.